Novo Holdings A/S 13D and 13G filings for Harmony Biosciences Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2021-05-21 4:34 pm Sale | 2021-05-11 | 13G | Harmony Biosciences Holdings, Inc. HRMY | Novo Holdings A/S | 2,416,254 4.200% | -1,206,217![]() (-33.30%) | Filing |
2021-02-08 5:01 pm Sale | 2020-12-31 | 13G | Harmony Biosciences Holdings, Inc. HRMY | Novo Holdings A/S | 3,622,471 6.400% | -132,502![]() (-3.53%) | Filing |
2020-09-04 4:30 pm Sale | 2020-08-31 | 13G | Harmony Biosciences Holdings, Inc. HRMY | Novo Holdings A/S | 3,754,973 6.600% | -654,830![]() (-14.85%) | Filing |
2020-08-25 4:30 pm Purchase | 2020-08-18 | 13G | Harmony Biosciences Holdings, Inc. HRMY | Novo Holdings A/S | 4,409,803 6.900% | 4,409,803![]() (New Position) | Filing |